HRP980406A2 - Thermodynamically stable modification of 1-(4-carbazolyloxy-3-/2-(2-methoxyphenoxy)ethylamino/-2-propanole, process for its preparation and pharmaceutical compositions containing it - Google Patents

Thermodynamically stable modification of 1-(4-carbazolyloxy-3-/2-(2-methoxyphenoxy)ethylamino/-2-propanole, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
HRP980406A2
HRP980406A2 HR97112491.2A HRP980406A HRP980406A2 HR P980406 A2 HRP980406 A2 HR P980406A2 HR P980406 A HRP980406 A HR P980406A HR P980406 A2 HRP980406 A2 HR P980406A2
Authority
HR
Croatia
Prior art keywords
carbazolyloxy
methoxyphenoxy
ethylamino
modification
preparation
Prior art date
Application number
HR97112491.2A
Other languages
English (en)
Croatian (hr)
Inventor
Peter Beyer
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HRP980406A2 publication Critical patent/HRP980406A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HR97112491.2A 1997-07-22 1998-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy-3-/2-(2-methoxyphenoxy)ethylamino/-2-propanole, process for its preparation and pharmaceutical compositions containing it HRP980406A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97112491A EP0893440A1 (fr) 1997-07-22 1997-07-22 Une modification thermodynamique stabilisée de 1-(4-carbazolyloxy)-3[2-(2-methoxyphenoxy)ethylamino]- 2-propanole, un procédé pour sa préparation et une composition pharmaceutique qui la contient

Publications (1)

Publication Number Publication Date
HRP980406A2 true HRP980406A2 (en) 1999-04-30

Family

ID=8227094

Family Applications (1)

Application Number Title Priority Date Filing Date
HR97112491.2A HRP980406A2 (en) 1997-07-22 1998-07-22 Thermodynamically stable modification of 1-(4-carbazolyloxy-3-/2-(2-methoxyphenoxy)ethylamino/-2-propanole, process for its preparation and pharmaceutical compositions containing it

Country Status (31)

Country Link
EP (2) EP0893440A1 (fr)
JP (1) JP2001510824A (fr)
KR (1) KR100336229B1 (fr)
CN (1) CN1125047C (fr)
AR (1) AR015133A1 (fr)
AT (1) ATE236123T1 (fr)
AU (1) AU740453B2 (fr)
BR (1) BR9810776A (fr)
CA (1) CA2296637C (fr)
CZ (1) CZ296947B6 (fr)
DE (1) DE69812964T2 (fr)
DK (1) DK1000027T3 (fr)
ES (1) ES2195366T3 (fr)
HR (1) HRP980406A2 (fr)
HU (1) HUP0003198A3 (fr)
IL (1) IL133677A (fr)
MA (1) MA26523A1 (fr)
MY (1) MY117734A (fr)
NO (1) NO313588B1 (fr)
NZ (1) NZ502136A (fr)
PE (1) PE96999A1 (fr)
PL (1) PL191602B1 (fr)
PT (1) PT1000027E (fr)
RU (1) RU2202542C2 (fr)
SI (1) SI1000027T1 (fr)
TR (1) TR200000148T2 (fr)
TW (1) TW505631B (fr)
UY (1) UY25108A1 (fr)
WO (1) WO1999005105A1 (fr)
YU (1) YU2200A (fr)
ZA (1) ZA986475B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003528914A (ja) * 2000-04-03 2003-09-30 エフ．ホフマン−ラ ロシュ アーゲー カルベジロールの濃縮溶液
EP1655285A1 (fr) * 2000-06-28 2006-05-10 Teva Pharmaceutical Industries Ltd. Procédé de préparation d'une forme crystalline de carvedilol (forme II)
JP2004501191A (ja) 2000-06-28 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド カルベジロール
AU2002326391A1 (en) * 2001-07-13 2003-01-29 Smithkline Beecham Corporation Carvedilol polymorph
ATE381924T1 (de) 2001-09-21 2008-01-15 Egalet As Feste dispersionen mit kontrollierter freisetzung von carvedilol
WO2003029214A1 (fr) * 2001-09-28 2003-04-10 F. Hoffmann-La Roche Ag Formes pseudopolymorphes de carvedilol
KR20040077872A (ko) 2002-01-15 2004-09-07 테바 파마슈티컬 인더스트리즈 리미티드 카베디롤의 결정질 고체 및 그 제조 방법
AU2003231283A1 (en) * 2002-04-30 2003-11-17 Sb Pharmco Puerto Rico Inc. Carvedilol monocitrate monohydrate
JP2005533822A (ja) 2002-06-27 2005-11-10 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド 臭化水素酸カルベジロール
KR101468827B1 (ko) 2002-06-27 2014-12-03 스미스클라인 비이참 (코르크) 리미티드 카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
AU2003275953A1 (en) * 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
WO2004084868A1 (fr) 2003-03-26 2004-10-07 Egalet A/S Systeme de liberation regulee de morphine
EP1615888A1 (fr) * 2003-04-21 2006-01-18 Matrix Laboratories Ltd Procede de fabrication de carvedilol, forme-ii
SI21616A (sl) * 2003-09-02 2005-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove kristalne oblike karvedilola
EP1686986A4 (fr) * 2003-11-25 2009-05-27 Sb Pharmco Inc Sels de carvedilol, compositions correspondantes, procedes d'administration et/ou de traitement
PT1838670E (pt) * 2004-12-09 2009-12-18 Zach System Spa Processo para a preparação de carvedilol e seus enantiómeros
EP1781611A1 (fr) * 2005-06-09 2007-05-09 Teva Pharmaceutical Industries Ltd. Formes cristallines du carvedilol et leurs procedes de preparation
WO2008002683A2 (fr) 2006-06-28 2008-01-03 Teva Pharmaceutical Industries Ltd. Carvédilol phosphate
RU2366653C2 (ru) * 2006-07-03 2009-09-10 Ооо "Нанокриохимия" Способ получения рентгеноаморфной модификации карведилола
US20080249317A1 (en) * 2007-04-04 2008-10-09 Apotex Inc. Novel amorphous form of carvedilol phosphate and processes for the preparation thereof
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (fr) 2009-02-06 2016-12-13 Egalet Ltd. Composition a liberation immediate resistant a une maltraitance par prise d'alcool
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung
DE3319027A1 (de) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von optisch aktiven carbazol-derivaten, neue r- und s-carbazol-derivate, sowie arzneimittel, die diese verbindungen enthalten

Also Published As

Publication number Publication date
EP0893440A1 (fr) 1999-01-27
IL133677A (en) 2004-06-01
CZ2000221A3 (cs) 2000-05-17
NO20000301L (no) 2000-01-21
TW505631B (en) 2002-10-11
HUP0003198A2 (en) 2001-03-28
CA2296637A1 (fr) 1999-02-04
KR20010022097A (ko) 2001-03-15
BR9810776A (pt) 2000-09-19
NO20000301D0 (no) 2000-01-21
AU740453B2 (en) 2001-11-01
DE69812964D1 (de) 2003-05-08
IL133677A0 (en) 2001-04-30
WO1999005105A1 (fr) 1999-02-04
NZ502136A (en) 2002-05-31
EP1000027B1 (fr) 2003-04-02
PE96999A1 (es) 1999-10-12
MA26523A1 (fr) 2004-12-20
DE69812964T2 (de) 2004-03-04
NO313588B1 (no) 2002-10-28
ES2195366T3 (es) 2003-12-01
JP2001510824A (ja) 2001-08-07
EP1000027A1 (fr) 2000-05-17
PT1000027E (pt) 2003-07-31
MY117734A (en) 2004-07-31
TR200000148T2 (tr) 2000-07-21
AR015133A1 (es) 2001-04-18
CN1125047C (zh) 2003-10-22
HUP0003198A3 (en) 2002-10-28
ZA986475B (en) 2000-01-21
DK1000027T3 (da) 2003-07-21
YU2200A (sh) 2002-03-18
CN1264366A (zh) 2000-08-23
SI1000027T1 (en) 2003-10-31
CA2296637C (fr) 2005-11-15
UY25108A1 (es) 2000-12-29
ATE236123T1 (de) 2003-04-15
AU8631998A (en) 1999-02-16
HK1029339A1 (en) 2001-03-30
CZ296947B6 (cs) 2006-08-16
KR100336229B1 (ko) 2002-05-09
PL191602B1 (pl) 2006-06-30
RU2202542C2 (ru) 2003-04-20
PL338432A1 (en) 2000-11-06

Similar Documents

Publication Publication Date Title
HRP980406A2 (en) Thermodynamically stable modification of 1-(4-carbazolyloxy-3-/2-(2-methoxyphenoxy)ethylamino/-2-propanole, process for its preparation and pharmaceutical compositions containing it
US6730326B2 (en) Thermodynamically stable modification of 1-(4-carbazolyl-oxy-3[2-(2-methoxyphenoxy)-ethylamino]-2-propanol process for its preparation and pharmaceutical compositions containing it
CA2305803C (fr) Olymorphe antifongique cristallin
AU2002255017B2 (en) Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid
KR100425656B1 (ko) 약제의결정변체
JPS61197577A (ja) １−置換−６−フルオロ−７−（ピロ−ル−１−イル）−１，４−ジヒドロ−４−オキソキノリン−３−カルボン酸誘導体およびその製造法
AU2003251974C1 (en) Novel salt and polymorphs of desloratadine hemifumarate
JPS6219577A (ja) 新規なベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物
US4438142A (en) Pharmaceutical combination
MXPA00000507A (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3- [2-(2-methoxyphenoxy)ethylamino]-2- propanole, process for its preparation and pharmaceutical compositions containing it
HK1029339B (en) Thermodynamically stable modification of 1-(4-carbazoly-loxy)-3-(2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it
MXPA06002732A (es) Compuesto de indol que contiene sulfonamida cristalina y proceso para su preparacion.
PL205568B1 (pl) Polimorf 1 bilastyny, sposoby jego wytwarzania, preparaty farmaceutyczne go zawierające oraz jego zastosowanie
HK1029588B (en) Crystalline antifungal polymorph

Legal Events

Date Code Title Description
A1OB Publication of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ROCHE DIAGNOSTICS GMBH, DE

AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBI Application refused